The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.
“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for ...
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of ...
Then, tell the FDA’s MedWatch Adverse Event Reporting Program, either online or by calling 800-332-1088 to request a reporting form. Since 1989, David J. Neal’s domain at the Miami Herald has ...
Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...